Cardiometabolic medication exposures and cognitive outcomes in Alzheimer’s disease
Abstract Background People with dementia are often prescribed cardiometabolic medications; however, the impact of this medication exposome on cognitive trajectories remains unclear. Methods We analysed data from National Alzheimer’s Coordinating Center (n = 28 044), Australian Imaging, Biomarkers and Lifestyle study (n...